Synopsys (SNPS) FY2017 results: revenue $2.7 billion, up 12.5% on the year
Synopsys Inc. (SNPS) reported revenue of $2.7 billion for fiscal 2017, the year ended 31 October 2017, up 12.5% on the year before. Net income was $137 million, down 48.8%, and diluted earnings per share $0.88. The figures are the company's own, from the 10-K it filed with the SEC on 14 December 2017.
Revenue
$2.7 billion
+12.5% on the year
FY2010FY2017
Operating margin
12.8%
13.1% a year earlier
FY2010FY2017
Net income
$137 million
-48.8% on the year
FY2010FY2017
Diluted EPS
$0.88
-49.1% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
2,725
2,423
2,242
+12.5%
Cost of revenue
654
543
519
+20.5%
Gross profit
2,071
1,880
1,723
+10.2%
Gross margin
76.0%
77.6%
76.9%
Research and development
909
857
776
+6.1%
Operating income
348
317
266
+9.5%
Operating margin
12.8%
13.1%
11.9%
Interest expense
7.3
3.8
2.8
+93.7%
Pre-tax income
383
330
282
+16.2%
Income tax
247
62.7
55.7
+293.1%
Effective tax rate
64.4%
19.0%
19.8%
Net income
137
267
226
-48.8%
Net margin
5.0%
11.0%
10.1%
Diluted EPS
$0.88
$1.73
$1.43
-49.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
632
587
495
+7.8%
Capital expenditure
70.3
66.9
87.0
+5.1%
Free cash flow
562
520
408
+8.2%
Free cash flow margin
20.6%
21.5%
18.2%
Cash from investing
-189
n/a
n/a
Cash from financing
-373
n/a
n/a
Depreciation and amortisation
189
207
212
-8.5%
Share-based compensation
108
97.6
86.4
+11.0%
Buybacks
380
400
260
-5.0%
Diluted shares, weighted
155m
155m
158m
+0.1%
Shares outstanding at period end
150m
151m
155m
-0.7%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
3,276
3,195
3,134
+2.5%
Non-controlling interest
4.1
0.0
n/a
Debt
144
205
205
-29.8%
Other liabilities
1,973
1,840
1,707
+7.2%
Total liabilities and equity
5,396
5,240
5,046
+3.0%
Fixed assets
266
257
263
+3.5%
Goodwill
2,707
2,518
2,471
+7.5%
Intangible assets
254
267
364
-4.8%
Investments
0.0
141
129
Cash and equivalents
1,048
977
836
+7.3%
Receivables
451
439
386
+2.8%
Inventory
61.9
n/a
n/a
Other assets
608
642
597
-5.3%
Total assets
5,396
5,240
5,046
+3.0%
10-K for the year ended 31 October 2017, filed 14 December 2017: the filing.